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Abstracts

The clinical features and treatment of pulmonary tuberculosis patients with COVID-19 is
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unclear and understudied. Here, three pulmonary tuberculosis patients with COVID-19
infection were prospectively followed from hospital admission to discharge. We provide
information and experience with treatment of pulmonary tuberculosis cases with confirmed
COVID-19 infection.

Dear editor,

The World Health Organization (WHO) declared the outbreak of novel coronavirus
(COVID-19) a Public Health Emergency of international on Jan 30, 2020 1. It is well
documented that certain viral infections, such as measles, have been known to aggravate
pulmonary tuberculosis (TB), presumably as a result of depressed cellular immunity 2,3.
Despite their vulnerability as a population, to date, most studies have focused on COVID-19
infection in patients without current respiratory disease. The clinical features and treatment of
tuberculosis patients with COVID-19 are unclear and understudied. To our knowledge, the
coinfection of SARS-CoV-2 and mycobacterium tuberculosis (TB) has not been reported
previously. Therefore, we provide information and experience with treatment of tuberculosis
cases with confirmed COVID-19 infection.

The data was derived from 139 confirmed cases, which were hospitalized in Wenzhou Sixth
People’s hospital from January 17, 2020, to Mar 6th, 2020. Three tuberculosis cases with

This article is protected by copyright. All rights reserved.

COVID-19 infection were confirmed by a real-time fluorescence polymerase chain reaction
assay. All three patients were males, ages 26 to 76 years, and were prospectively followed
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from hospital admission to discharge.

Table 1 illustrates the clinical features, laboratory tests, clinical prognosis, treatments and
outcomes of the three patients. According to this epidemiological investigation, all patients
were in close contact and infected from others with confirmed infections of COVID-19.
Patient 1 and 2 had pulmonary tuberculosis history, and were administered quadruple
antituberculosis therapy, while patient 3 had untreated tuberculosis for 50 years. The
cavitating lesion of patient 3 in the right upper lobe remained unchanged for many years.
Considering the harmfulness of the SARS-CoV-2 specimen, the hospital restricted the
examination of sputum Xpert, T-SPOT.TB and culture of Mycobacterium tuberculosis, etc.
The onset of their symptoms varied from dry cough, chest tightness to persistent fever. Other
symptoms included chest pain, diarrhea, and dyspnea. Patient 1 and patient 3, who were of
older age, had hypoxemia and developed a critical type and severe type of COVID-19
respectively. Laboratory tests showed all of them had low lymphocyte count and increased
levels of CRP, LDH and ESR. Computed tomography scans showed all of the cases presented
with multiple bilateral ground-glass opacities and consolidation, with air bronchogram.

All the patients had antivirus therapy including lopinavir, ritonavir, and arbidol with a long
prognosis. Patient 1 progressed to respiratory failure type 1 and acute respiratory distress
syndrome (ARDS) on Day 10 after onset. He had treatment of noninvasive ventilation support.
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Both patients 1 and 3 were severe cases and had treatment of methyl prednisolone. Since
patient 3 had untreated tuberculosis for many years, he received antituberculosis therapy
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combined with glucocorticoid therapy. Cases 1 and 3 both had glucose level abnormalities
and bacterial infections. They were put on antibiotic therapy and the symptoms relieved later.
Patient 2 developed skin rashes with pruritus all over his body, which is considered an adverse
reaction of the antiviral treatment. His symptoms improved after he stopped the antivirus
therapy. All of the patients recovered and were discharged from the hospital. However on the
9th day after discharge, patient 2 had a positive recurrence of SARS-CoV-2 RNA and
returned to the hospital to remain in isolation and under observation.

Among these three COVID-19 combined TB patients, two who were older in age developed
severe cases of COVID-19, and one which was ARDS. All had a long recovery and it was
difficult to resolve the problem of low Oxygenation Index (OI). The CT images showed the
COVID-19 lesions and tuberculosis lesions coexist and performed differently (Figure 1 and
figure S1). The COVID-19 lesions were mainly performed as ground glass lesions and
consolidation, mainly located in the peripheral zone. Mycobacterium tuberculosis lesions were
mainly performed as stripe of high density shadow with cavitating lesion, mainly located in
the upper lung. Limited by the small sample size, we cannot draw the conclusion. Future large
sample sized study address on pathology of COVID with CT imagining are warranted.

TB is the type of infection that requires cellular immunity, and nearly one hundred years ago
lung function studies with TB showed evidence of restrictive lung disease. In patients infected
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with Mycobacterium tuberculosis, whether treated or untreated, a variety of pulmonary and
extrapulmonary sequelae and complications can occur, which include bronchiectasis,
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tracheobronchial stenosis, and broncholithiasis 4. Structural changes lead to obstructive,
restrictive, or mixed patterns of impaired pulmonary function. Studies in patients with
pulmonary tuberculosis (PTB) have demonstrated that 33.3-94.0% of such patients develop
impaired pulmonary function 5. The risk factors for TB patients with reduced pulmonary
function are having previously had culture-positive PTB, being over 50 years of age, having a
low level of education, and having experienced recurrence of tuberculosis6. This study
suggests that previous lung disease such as treated or untreated mycobacterium tuberculosis
(TB) and old age are independent risk factors of a worse prognosis of those infected with
COVID-19. Using a glucocorticoid for a short period of time in the early stages of prognosis
could reduce the inflammation, but longer-term usage could result in the risk of bacterial
infections and abnormal glucose levels. These case reports remind us of the importance of
strict isolation of COVID-19 patients, careful use of steroids for their case management, and
the possibility of coinfection with TB in COVID-19 patients with incomplete recovery.

The presented case series demonstrates pulmonary tuberculosis patients with COVID-19. In
this study, elderly patients with tuberculosis easily progressed to the severe type of
COVID-19 and had a long recovery process. These case reports remind us of the possibility of
coinfection with TB in COVID-19 patients with incomplete recovery, as well as the
importance of careful use of steroids for their case management.
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Figure Legend

Figure1. Axial CT images of chest in patient 3 with the COVID-19 and
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tuberculosis coinfection. (a) CT obtained on day 2. (a1) Stripe of high density
shadow with cavitating lesion in right upper lobe. (a2) Stripe of high density
shadow in right upper lobe.(a3) Pathy ground-glass opacities (GGO) in left lower
lobe. (b) CT obtained on day 7.(b1) Stripe of high density shadow with cavitating
lesion in right upper lobe, slight GGO in left upper lobe. (b2) Stripe of high
density shadow on right middle lobe, subpleural (GGOs) in the right upper lobe.
Multifocal, limited GGO is seen in the left lungs.(b3) Increased multiple
ground-glass opacities and consolidation in left lower lobe with air
bronchograms.(c) CT obtained on day 16. (c1) Stripe of high density shadow with
cavitating lesion in right upper lobe, slight GGO in left upper lobe. (c2) Stripe of
high density shadow on right middle lobe, absorption of GGO bilaterally.(c3)
GGO and consolidation in left lower lobe. (d) CT obtained on day 22. (d1) Stripe
of high density shadow with cavitating lesion in right upper lobe, absorption of
GGO in left upper lobe. (d2) Stripe of high density shadow on right middle lobe,
absorption of GGO bilaterally.(d3) GGO and consolidation in left lower lobe.(e)
Follow-up CT obtained on day 59. (e1) Stripe of high density shadow with
cavitating lesion in right upper lobe. (e2) Stripe of high density shadow on right
middle lobe, absorption of GGO bilaterally.(e3) absorption of GGO in left lower
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lobe. Yellow arrow demonstrated the lesion of tuberculosis. Green arrow
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demonstrated the lesion of COVID-19.

Table 1． Illustrates the clinical features, laboratory tests, clinical prognosis, treatments
and outcomes of the three patients.
Patient Number

1

2

3

Age (years)

67

26

76

Gender (M/F)

M

M

M

BMI

24.2

28.73

17.96

Past history

TB (Treated 6years ago)

TB (treated 2 year ago)

TB (for 50 years,
non-treated)

HBP
Exfoliative dermatitis
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Arthrolithiasis

Smoking history

+

-

+

Imported case from Wuhan

+

+

-

Fever (Tmax,℃)

38.9

38.2

38.9

Dry cough

+

+

+

Chest tightness

+

-

+

Chest pain

-

-

+

Dyspnea

+

-

+

Diarrhea

-

+

-

Family cluster

+

+

+

Oxygen saturation on room air (%)

89↓

97

96

Respiratory rate

22

19

20

Lowest leukocyte count(×109/liter)

3.3↓

3.2↓

3.9↓

Lowest lymphocyte count(×109/liter)

0.5↓

0.8↓

0.3↓

Lowest PaO2 (kPa)

6.7↓ (FiO2 33%)

NA

9.3↓ (FiO2 33%)

Highest serum ALT* (U/L)

39

33

22

Lowest serum ALB † (g/L)

32.5↓

43.9

31.6↓

Highest serum CKP ‡ (U/L)

142

41.1

105

Highest serum LDH§ (U/L)

396↑

372↑

328↑

Highest CRP (mg/L)

124.2↑

29.2↑

77.1↑

Highest ESR (mm/h)

91↑

NA

38↑
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Clinical features

Laboratory findings
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Radiological findings of thorax (Radiograph /Computed tomography)
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Initial change

Multiple bilateral mass

Multiple ground-glass

Pathy

ground-glass

opacities on lower lobe

opacities on left lower

stripe of high density

bilaterally, with

lobe,

shadow on right upper

mediastinal

density

lobe （Day7）

lymphadenopathy (Day

right upper lobe with

9)

cavitating lesion in the

opacities,

ground-glass

stripe of

high

shadow

on

upper lobe of the right
lung. (Day 2)

Progressive change

Increased bilateral

Absorption of the

Increased multiple

multiple ground-glass

ground-glass opacities

ground-glass opacities

opacities and

(Day 20)

and consolidation on

consolidation (Day 13)

lower lobe bilaterally
Absorption of some area
(Day 5)

Absorption of some area

(Day 43)

(Day 18)

Absorption of some
area (Day 10)

Absorption than Day18
Increased
(Day 24)
consolidation (Day 15)
Unchanged image
Increased
(Day35)
consolidation (Day 22)
Absorption of some area
Absorption of some
(Day 40)
area (Day 28)

Comorbid conditions

Hyoxemia

+

-

+

Glucose level abnormal

+

-

+

ARDS¶

+

-

-

Bacterial infection

+

+

+

Medicine rash

-

+

-
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Treatment and outcome
Aerosol therapy with interferonα-2b

+

+

+

Antivirus medicine

Lopinavir + Ritonavir

Lopinavir + Ritonavir

Lopinavir + Ritonavir

Arbidol

Arbidol

Arbidol

Methyl prednisolone

+ (Day10-Day11)

-

+ (Day5-Day12)

Antibiotics

+

+

+

Antituberculosis

-

-

+

Probiotics

+

+

+

Traditional Chinese medicine

+

+

+

Intravenous immunoglobulin

+

-

+

Ventilatory support

Noninvasive ventilation

-

Nasal cannula

Maximum oxygen requirement (FiO2)

50%

-

41%

Outcome of symptoms

Relief

Relief

Relief

Last OI# 325

Hospital stay (days)

37

Last OI 396

28

24

ALT*=alanine aminotransferase. ALB†=albumin. CKP‡=creatine kinase. LDH§=lactic
dehydrogenase. ARDS¶=Acute respiratory distress syndrome. OI# = Oxygenation Index=
PaO2/FiO2.
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